Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€263.80

€263.80

1.110%
2.9
1.110%
€300.13
 
08.08.25 / Tradegate WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction

Financial data and news for Insulet

sharewise wants to provide you with the best news and tools for Insulet, so we directly link to the best financial data sources.

News

3 Medical Technology Stocks Outperforming in 2025: https://www.marketbeat.com/logos/articles/med_20250605161905_3-medical-technology-stocks-outperforming-in-2025.png
3 Medical Technology Stocks Outperforming in 2025

As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer: https://www.marketbeat.com/logos/articles/med_20250513152714_insulet-earnings-propel-stock-and-an-sp-500-leader.jpg
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer
[content-module:CompanyOverview|NASDAQ:PODD]

Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the

Insulet (PODD) Q2 Revenue Jumps 33%
Insulet (PODD) Q2 Revenue Jumps 33%

Insulet (NASDAQ:PODD), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong